Your Complete Guide To Starting Either Treatment Safely
Understanding Mounjaro And Wegovy Equivalent Doses For First-Time Users
When comparing Mounjaro and Wegovy equivalent doses at the starting level, it's essential to understand that these medications follow different escalation protocols despite both supporting weight management. Wegovy (semaglutide) begins with a 0.25mg dose for weeks 1-4, designed to help your body gradually adjust to the GLP-1 receptor agonist mechanism. Mounjaro (tirzepatide) also starts at 2.5mg weekly, offering a dual GIP and GLP-1 receptor approach that some patients find helpful during their initial weeks.
The starting doses for both medications serve the same fundamental purpose: minimising potential side effects whilst allowing your appetite regulation system to adapt slowly. Neither medication allows you to skip the initial low-dose phase, as this gradual introduction is crucial for both safety and long-term treatment success. Your prescriber will determine which starting approach aligns best with your medical history and weight management goals.
Wegovy Starter Dose Pricing And Bundle Options For New Patients
Wegovy's 0.25mg starter dose costs £79.99 through EverydayMeds, with new customers applying code FIRST40 at checkout to reach this price. For patients planning ahead, our Intro Duo bundle provides both your 0.25mg and 0.5mg doses for £169.99, covering your first eight weeks of treatment. This bundle approach ensures continuity of supply without requiring separate orders during your initial escalation phase.
Returning customers can use code DOSE25 for their ongoing prescriptions, whilst the Gentle Start Trio (containing 0.25mg, 0.25mg, and 0.5mg) allows for extended low-dose tolerance building at £269.99. All prices include clinical assessment, prescriber review, and next-day cold-chain delivery once approved. Payment plans are available for patients preferring to spread costs across their treatment journey.
Clinical Evidence Behind Mounjaro And Wegovy Equivalent Doses In STEP Trials
The STEP clinical trial programme, published by Wilding et al. in NEJM 2021, demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo. These results specifically followed the dose escalation protocol starting from 0.25mg, highlighting the importance of the graduated approach. The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events among patients following this same dosing schedule.
Mounjaro's clinical evidence comes from the SURMOUNT trials, showing the effectiveness of tirzepatide's dual-hormone approach when following its own specific dose escalation. Both medications require prescription-only access and ongoing medical supervision, with individual results varying based on adherence to the complete treatment protocol including dietary modifications.
How Wegovy's GLP-1 Mechanism Compares To Mounjaro's Dual Approach
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, working primarily on brain appetite centres to reduce hunger and promote satiety after smaller meals. This single-hormone approach has been extensively studied and may help reduce food cravings whilst supporting portion control. The 0.25mg starting dose allows this mechanism to engage gradually, reducing the likelihood of pronounced gastrointestinal effects. Mounjaro's tirzepatide targets both GLP-1 and GIP receptors, offering a dual-hormone approach that some patients find beneficial during their weight management journey. Both mechanisms require the medication to be taken alongside a reduced-calorie diet and increased physical activity for optimal results.
EverydayMeds Ordering Process For Mounjaro And Wegovy Equivalent Doses
Starting either Wegovy or Mounjaro through EverydayMeds begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring each prescription-only medicine is appropriate for your individual circumstances. Once approved, your starter dose ships via next-day delivery using temperature-controlled packaging to maintain medication stability. The GPhC-registered pharmacy service (#9012878) includes ongoing prescriber support throughout your dose escalation journey. Follow-up prescriptions can be ordered through your patient portal, with automatic reminders helping maintain treatment continuity.
Storage Requirements And Practical Considerations For Starting Doses
Both Wegovy and Mounjaro require refrigerated storage at 2-8°C before first use, though Wegovy offers superior travel flexibility with 6 weeks room temperature stability versus Mounjaro's 21 days once removed from the fridge. The Wegovy FlexTouch pen system provides clear dose confirmation and easy injection technique, particularly helpful for first-time users adjusting to weekly injections. Your starter dose pen contains four weekly injections, with clear markings showing remaining medication levels. Proper storage becomes especially important when ordering bundles like the Intro Duo, ensuring your follow-up doses maintain their effectiveness. Both medications use single-use needles that should be removed after each injection to prevent contamination.
Why Starting Doses Cannot Be Adjusted For Mounjaro And Wegovy Equivalent Treatment
The specific starting doses for both Wegovy (0.25mg) and Mounjaro (2.5mg) are clinically determined and cannot be modified, even if you're eager to see faster results. This graduated approach isn't just regulatory requirement—it's based on extensive clinical evidence showing that patients who skip or rush the escalation phase experience significantly higher discontinuation rates due to side effects. Your prescriber cannot authorise starting at higher doses, as this would fall outside the licensed indication for both medications.
The 16-week escalation schedule for Wegovy, moving through 0.25mg, 0.5mg, 1mg, 1.7mg, to maintenance 2.4mg, allows your body's hormone receptors to adapt progressively. Similarly, Mounjaro's escalation follows its own evidence-based timeline that cannot be accelerated. Patients often find that appetite changes begin within the first few weeks at starter doses, making the gradual approach both safer and more sustainable long-term.
Begin Your Weight Management Journey With Expert Support From EverydayMeds
Whether you choose Wegovy starting from £79.99 or prefer Mounjaro's dual-hormone approach, EverydayMeds provides comprehensive support throughout your treatment journey. New customers can apply code FIRST40 at checkout, whilst returning patients use DOSE25 for ongoing prescriptions. Our clinical team, operating under GPhC registration #9012878, ensures each prescription-only medicine is dispensed safely with appropriate medical oversight. Order your starter dose today through our secure platform, with next-day delivery available once your prescription is approved. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment aligns best with your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
